Optic coherence tomography shows inflammation and degeneration in major depressive disorder patients correlated with disease severity

Journal of Affective Disorders

Volumn 204, Issue , 2016, Pages 159-165

  Kalenderoglu, Aysun ^a   Çelik, Mustafa ^a,b   Sevgi Karadag, Ayse ^a   Egilmez, Oguzhan Bekir ^a  

^a ADIYAMAN UNIVERSITY   (Turkey)

^b Psikiyatri Servisi ^*  (Turkey)

Author keywords

Ganglion cell layer; Inner plexiform layer; Major depressive disorder; Optic coherence tomography; Retinal nerve fiber layer

Indexed keywords

MIRTAZAPINE; NEUROLEPTIC AGENT; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; CHOROID THICKNESS; CLINICAL GLOBAL IMPRESSION SCALE; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; GANGLION CELL LAYER VOLUME; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; NERVE CELL; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NEUROIMAGING; OPTICAL COHERENCE TOMOGRAPHY DEVICE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RECURRENT DISEASE; RETINAL INNER PLEXIFORM LAYER; RETINAL INNER PLEXIFORM LAYER VOLUME; RETINAL NERVE FIBER LAYER THICKNESS; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; VISUAL SYSTEM PARAMETERS; CASE CONTROL STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC IMAGING; GRAY MATTER; INFLAMMATION; MIDDLE AGED; NERVE FIBER; OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY; PROCEDURES; RETINA GANGLION CELL; SEVERITY OF ILLNESS INDEX;

ADULT; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; GRAY MATTER; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; NERVE DEGENERATION; NERVE FIBERS; RECURRENCE; RETINAL GANGLION CELLS; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84975849800     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2016.06.039     Document Type: Article

References (50)

1. C. Armarcegui, I. Dolz, V. Pueyo, and E. Garcia Correlation between functional and structural assessments of the optic nerve and retina in multiple sclerosis patients Neurophysiol. Clin. 40 2010 129 135
2. M. Banasr, J.M. Dwyer, and R.S. Duman Cell atrophy and loss in depression: reversal by antidepressant treatment Curr. Opin. Cell Biol. 23 2011 730 737
3. E. Bora, A. Fornito, C. Pantelis, and M. Yücel Gray matter abnormalities in major depressive disorder: a meta analysis of voxel based morphometry studies J. Affect. Disord. 138 2012 9 18
4. E. Bromet, L.H. Andrade, I. Hwang, N.A., Sampson, J. Alonso, G. de Girolamo, R. de Graaf, K. Demyttenaere, C. Hu, N. Iwata, A.N. Karam, J. Kaur, S. Kostyuchenko, J.P. Lépine, D. Levinson, H. Matschinger, M.E. Mora, M.O. Browne, J. Posada-Villa, M.C. Viana, D.R. Williams, and R.C. Kessler Cross-national epidemiology of DSM-IV major depressive episode BMC Med. 9 2011 90
5. E. Bubl, E. Kern, D. Ebert, M. Bach, and L. Tebartz van Elst Seeing gray when feeling blue? Depression can be measured in the eye of the diseased Biol. Psychiatry 68 2 2010 205 208
6. E. Bubl, D. Ebert, E. Kern, L.T. van Elst, and M. Bach Effect of antidepressive therapy on retinal contrast processing in depressive disorder Br. J. Psychiatry J. Ment. Sci. 201 2012 151 158
7. M.S. Buckwalter, and T. Wiss-Coray Modelling neuroinflammatory phenotypes in vivo J. Neuroinflamm. 1 2004 10
8. L. Cabezon, F.J. Ascaso, P. Ramiro, M. Quintanilla, E.L. Gutierrez, and A. Lobo Optical coherence tomography: a window into the brain of schizophrenic patients Acta Ophthalmol. 90 2012 0
9. S. Campbell, and G. MacQueen An update on regional brain volume differences associated with mood disorders Curr. Opin. Psychiatry 19 2006 25 33
10. M. Celik, A. Kalenderoglu, A. Sevgi Karadag, O. Bekir Egilmez, B. Han-Almis, and A. Şimşek Decreases in ganglion cell layer and inner plexiform layer volumes correlate better with disease severity in schizophrenia patients than retinal nerve fiber layer thickness: findings from spectral optic coherence tomography Eur. Psychiatry 19 32 2016 9 15
11. E. Coskun, B. Gurler, Y. Pehlivan, B. Kisacik, S. Okumus, R. YayuspayI, E. Ozcan, and A.M. Onat Enhanced depth imaging optical coherence. tomography findings in Behcet disease Ocul. Immunol. Inflamm. 3 2013 1 6
12. A.J. Ferrari, F.J. Charlson, R.E. Norman, S.B. Patten, G. Freedman, C.J. Murray, T. Vos, and H.A. Whiteford Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010 PLoS Med. 10 11 2013 e1001547
13. K.N. Fountoulakis, F. Fotiou, A. Iacovides, and G. Kaprinis Is there a dysfunction in the visual system of depressed patients? Ann. Gen. Psychiatry 4 1 2005 7
14. J.G. Fujimoto Optical coherence tomography for ultrahigh resolution in vivo imaging Nat. Biotechnol. 21 2003 1361 1367
15. M.L. Gabriele, G. Wollstein, H. Ishikawa, L. Kagemann, J. Xu, L.S. Folio, and J.S. Schuman Optical coherence tomography: history, current status, and laboratory work Investig. Ophthalmol. Vis. Sci. 52 2011 2425 2436
16. J. Hanley Statistical analysis of correlated data using generalized estimating equations: an orientation Am. J. Epidemiol. 157 2003 364 375
17. B.L. Hart Biological basis of the behavior of sick animals Neurosci. Biobehav. Rev. 12 1988 123 137
18. K. Hashimoto, A. Sawa, and M. Iyo Increased levels of glutamate in brains from patients with mood disorders Biol. Psychiatry 62 2007 1310 1316
19. R. Inzelberg, J.A. Ramirez, P. Nisipeanu, and A. Ophir Retinal nerve fiber layer thinning in Parkinson disease Vis. Res. 44 24 2004 2793 2797
20. F. Honrubia, and B. Calonge Evaluation of the nerve fiber layer and peripapillary atrophy in ocular hypertension Int. Ophthalmol. 13 1989 57 62
21. J.A. Izatt, M.R. Hee, E.A. Swanson, C.P. Lin, D. Huang, J.S. Schuman, C.A. Puliafito, and J.G. Fujimoto Micrometer-scale resolution imaging of the anterior eye in vivo with optical coherence tomography Arch. Ophthalmol. 112 1994 1584 1589
22. H.J. Kang, B. Voleti, T. Hajszan, G. Rajkowska, C.A. Stockmeier, P. Licznerski, A. Le-pach, M.S. Majik, L.S. Jeong, M. Banasr, H. Son, and R.S. Duman Decreased expression of synapse-related genes and loss of synapses in major depressive disorder Nat. Med. 18 9 2012 1413 1417
23. A. Kalenderoglu, A. Sevgi-Karadag, M. Celik, O.B. Egilmez, B. Han-Almis, and M.E. Ozen Can the retinal ganglion cell layer (GCL) volume be a new marker to detect neurodegeneration in bipolar disorder? Compr. Psychiatry 67 2016 66 72
24. M. Kim, H. Kim, H.J. Kwon, S.S. Kim, H.J. Koh, and S.C. Lee Choroidal thickness in Behcet's üveitis: an enhanced depth imaging optical coherence tomography and its association with angiographic changes Investig. Ophthalmol. Vis. Sci. 54 9 2013 6033 6039
25. C. Lamirel, N. Newman, and V. Biousse The use of optical coherence tomography in neurology Rev. Neurol. Dis. 6 2009 105 120
26. M. Maes, E. Bosmans, E. Suy, C. Vandervorst, C. DeJonckheere, and J. Raus Depression-related disturbances in mitogen-induced lymphocyte responses and interleukin-1 beta and soluble interleukin-2 receptor production Acta Psychiatr. Scand. 84 4 1991 379 386
27. M. Maes, J. Lambrechts, E. Bosmans, J. Jacobs, E. Suy, C. Vandervorst, C. de Jonckheere, B. Minner, and J. Raus Evidence for a systemic immune activation during depression: results of leukocyte enumeration by flow cytometry in conjunction with monoclonal antibody staining Psychol. Med. 22 1 1992 45 53
28. M. Maes, S. Scharpe, H.Y. Meltzer, and P. Cosyns Relationships between increased haptoglobin plasma levels and activation of cellmediated immunity in depression Biol. Psychiatry 34 1993 690 701
29. M. Maes, E. Vandoolaeghe, H. Neels, P. Demedts, A. Wauters, H.Y. Meltzer, C. Altamura, and R. Desnyder Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness Biol. Psychiatry 42 1997 349 358
30. C.G. Mason Ocular accumulation and toxicity of certain systemically administered drugs J. Toxicol. Environ. Health A 2 5 1977 977 995
31. T.A. Meredith, T.M. Aaberg, and W.D. Willerson Progressive chorioretinopathy after receiving thioridazine Arch. Ophthalmol. 96 1978 1172 1176
32. L.M. Parver Temperature modulating action of choroidal blood flow Eye 5 1991 181 185
33. E. Polazzi, and A. Contestabile Reciprocal interactions between microglia and neurons: from survival to neuropathology Rev. Neurosci. 13 2002 221 242
34. H.A. Quigley, and E.M. Addicks Quantitative studies of retinal nerve fiber layer defects Arch. Ophthalmol. 100 1982 807 814
35. L. Qin, X. Wu, M.L. Block, Y. Liu, G.R. Breese, J.S. Hong, D.J. Knapp, and F.T. Crews Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration Glia 55 2007 453 462
36. C.L. Raison, L. Capuron, and A.H. Miller Cytokines sing the blues: Inflammation and the pathogenesis of major depression Trends Immunol. 27 2006 24 31
37. N.M. Roth, S. Saidha, H. Zimmermann, A.U. Brandt, J. Isensee, A. Benkhellouf-Rutkowska, M. Dornauer, A.A. Kühn, T. Müller, P.A. Calabresi, and F. Paul Photoreceptor layer thinning in idiopathic Parkinson's disease Mov. Disord. 29 9 2014 1163 1170
38. S. Saidha, S.B. Syc, M.K. Durbin, C. Eckstein, J.D. Oakley, and S.A. Meyer Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness Mult. Scler. 17 12 2011 1449 1463
39. S. Saidha, O. Al-Louzi, J.N. Ratchford, P. Bhargava, J. Oh, S.D. Newsome, J.L. Prince, D. Pham, S. Roy, P. van Zijl, L.J. Balcer, E.M. Frohman, D.S. Reich, C. Crainiceanu, and P.A. Calabresi Optical coherence tomography reflects brain atrophy in multiple sclerosis: a four-year study Ann. Neurol. 78 5 2015 801 813
40. C. Schönfeldt-Lecuona, T. Kregel, A. Schmidt, E.H. Pinkhardt, F. Lauda, J. Kassubek, and M. Gahr From Imaging the Brain to Imaging the Retina: Optical Coherence Tomography (OCT) in Schizophrenia Schizophr. Bull. 42 1 2015 9 14
41. J.S. Schuman, M.R. Hee, C.A. Puliafito, C. Wong, T. Pedut-Kloizman, C.P. Lin, E. Hertzmark, J.A. Izatt, E.A. Swanson, and J.G. Fujimoto Quantification of nerve fiber layer thickness in normal and glaucomatous eyes using optical coherence tomography Arch. Ophthalmol. 113 1995 586 596
42. J.A. Schmidt, W.J. Riedel, E.F. Vuurman, M. Kruizinga, and J.G. Ramaekers Modulation of the critical flicker fusion effects of serotonin reuptake inhibitors by concomitant pupillary changes Psychopharmacology 160 4 2002 381 386
43. T. Schwitzer, J. Lavoie, A. Giersch, R. Schwan, and V. Laprevote The emerging field of retinal electrophysiological measurements in psychiatric research: a review of the findings and the perspectives in major depressive disorder J. Psychiatr. Res. 70 2015 113 120
44. Seroquel (quetiapine) [package insert], 2001. Zeneca PharmaceuticalsWilmington, DE.
45. P.J. Shah, K.P. Ebmeier, M.F. Glabus, and G.M. Goodwin Cortical grey matter reductions associated with treatment-resistant chronic unipolar depression. Controlled magnetic resonance imaging study Br. J. Psychiatry 172 1998 527 532
46. Y.I. Sheline Neuroimaging studies of mood disorder: effects on the brain Biol. Psychiatry 54 2003 338 352
47. S. Stricker, T. Oberwahrenbrock, H. Zimmermann, J. Schroeter, M. Endres, A.U. Brandt, and F. Paul Temporal retinal nerve fiber loss in patients with spinocerebellar ataxia type 1 PLoS One 6 7 2011 e23024
48. M. Takeuchi, T. Iwasaki, T. Kezuka, Y. Usui, Y. Okunuki, J. Sakai, and H. Goto Functional and morphological changes in the eyes of Behçet's patients with uveitis Acta Ophthalmol. 88 2 2010 257 262
49. M. Yildiz, S. Alim, S. Batmaz, S. Demir, E. Songur, H. Ortak, and K. Demirci Duration of the depressive episode is correlated with ganglion cell inner plexiform layer and nasal retinal fiber layer thicknesses: optical coherence tomography findings in major depression Psychiatry Res. 18 251 2016 60 66
50. E.P. Zorilla, L. Luborsky, J.R. McKay, R. Roesnthal, A. Houldin, and A. Tax The relationship of depression and stressors to immunological assays: a meta-analytic review Brain Behav. Immun. 15 2001 199 226